Lexicon Genetics Announces Public Offering of Common Stock
Wednesday July 16, 2:00 am ET
THE WOODLANDS, Texas, July 16 /PRNewswire-FirstCall/ -- Lexicon Genetics Incorporated (Nasdaq: LEXG - News) today announced it plans to sell 10.0 million shares of its common stock pursuant to an effective shelf registration statement previously filed with the Securities and Exchange Commission. The underwriters have the option to purchase up to an additional 1.5 million shares of common stock from Lexicon to cover over-allotments, if any. Lexicon currently intends to use the net proceeds for research and development.
The offering will be joint lead managed by Morgan Stanley & Co. Incorporated and UBS Securities LLC. CIBC World Markets Corp. and Punk, Ziegel & Company, L.P. will also serve as managing underwriters for the offering. Morgan Stanley will serve as sole bookrunner for the offering.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities. The offering is being made solely by means of a prospectus dated December 6, 2002 and the accompanying prospectus supplement dated July 16, 2003. There shall not be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
Copies of the prospectus relating to the offering may be obtained by contacting Morgan Stanley & Co. Incorporated, 1585 Broadway, New York, NY 10036 or UBS Securities LLC, 299 Park Avenue, New York, NY 10171. |
